Werbung
Werbung

NEUP

NEUP logo

Neuphoria Therapeutics Inc. Common Stock

4.17
USD
Gesponsert
+0.10
+2.58%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

4.24

+0.07
+1.65%

NEUP Ergebnisberichte

Positives Überraschungsverhältnis

NEUP übertreffen die 0 der letzten 2Schätzungen.

%

Nächster Bericht

Datum des nächsten Berichts
12. Feb. 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$1.49
Implizierte Änderung von Q1 26 (Revenue/ EPS)
--
/
-66.21%
Implizierte Änderung von Q2 25 (Revenue/ EPS)
--
/
--

Neuphoria Therapeutics Inc. Common Stock earnings per share and revenue

On 14. Nov. 2025, NEUP reported earnings of -4.41 USD per share (EPS) for Q1 26, missing the estimate of -1.35 USD, resulting in a -225.89% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.84% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -1.49 USD, with revenue projected to reach -- USD, implying an decrease of -66.21% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q1 2026, Neuphoria Therapeutics Inc. Common Stock reported EPS of -$4.41, missing estimates by -225.89%, and revenue of $0.00, 0% as expectations.
The stock price moved up 0.84%, changed from $4.75 before the earnings release to $4.79 the day after.
The next earning report is scheduled for 12. Feb. 2026.
Based on 5 analysts, Neuphoria Therapeutics Inc. Common Stock is expected to report EPS of -$1.49 and revenue of -- for Q2 2026.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung